Chronic open-angle glaucoma

Also known as: Chronic simple glaucoma / Primary open-angle glaucoma / Primary open angle glaucoma

Drug	Drug Name	Drug Description
DB00521	Carteolol	A beta adrenergic antagonist used to treat arrhythmia, angina, hypertension, and glaucoma.
DB00449	Dipivefrin	A prodrug of epinephrine used in ophthalmic solutions to reduce intraocular pressure in chronic open-angle glaucoma.
DB01085	Pilocarpine	A muscarinic agonist used to treat dry mouth and various ophthalmic conditions, such as presbyopia, increased intraocular pressure, and angle-closure glaucoma.

Drug	Drug Name	Target	Type
DB00521	Carteolol	Beta-2 adrenergic receptor	target
DB00521	Carteolol	Beta-1 adrenergic receptor	target
DB00521	Carteolol	Cytochrome P450 2D6	enzyme
DB00449	Dipivefrin	Alpha-2A adrenergic receptor	target
DB00449	Dipivefrin	Cholinesterase	target
DB00449	Dipivefrin	Beta-2 adrenergic receptor	target
DB00449	Dipivefrin	Alpha-1A adrenergic receptor	target
DB00449	Dipivefrin	Acetylcholinesterase	target
DB01085	Pilocarpine	Muscarinic acetylcholine receptor M1	target
DB01085	Pilocarpine	Muscarinic acetylcholine receptor M2	target
DB01085	Pilocarpine	Cytochrome P450 2A6	enzyme
DB01085	Pilocarpine	Muscarinic acetylcholine receptor M3	target
DB01085	Pilocarpine	Cytochrome P450 3A4	enzyme
DB01085	Pilocarpine	Muscarinic acetylcholine receptor M4	target
DB01085	Pilocarpine	Muscarinic acetylcholine receptor M5	target
DB01085	Pilocarpine	Serum paraoxonase/arylesterase 1	enzyme

Drug	Drug Name	Phase	Status	Count